Effects of 12 weeks' treatment with a proton pump inhibitor on insulin secretion, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind prospective placebo-controlled study

K D Hove, Cecilie Brøns, Kai Erik Vinther Færch, S S Lund, J S Petersen, A E Karlsen, Pia Rossing, J F Rehfeld, A Vaag